235 related articles for article (PubMed ID: 18477809)
1. Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes.
Tedesco L; Valerio A; Cervino C; Cardile A; Pagano C; Vettor R; Pasquali R; Carruba MO; Marsicano G; Lutz B; Pagotto U; Nisoli E
Diabetes; 2008 Aug; 57(8):2028-36. PubMed ID: 18477809
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways.
Tedesco L; Valerio A; Dossena M; Cardile A; Ragni M; Pagano C; Pagotto U; Carruba MO; Vettor R; Nisoli E
Diabetes; 2010 Nov; 59(11):2826-36. PubMed ID: 20739683
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes.
Perwitz N; Wenzel J; Wagner I; Büning J; Drenckhan M; Zarse K; Ristow M; Lilienthal W; Lehnert H; Klein J
Diabetes Obes Metab; 2010 Feb; 12(2):158-66. PubMed ID: 19895638
[TBL] [Abstract][Full Text] [Related]
4. NOS isoform-specific regulation of basal but not exercise-induced mitochondrial biogenesis in mouse skeletal muscle.
Wadley GD; Choate J; McConell GK
J Physiol; 2007 Nov; 585(Pt 1):253-62. PubMed ID: 17916611
[TBL] [Abstract][Full Text] [Related]
5. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.
Bensaid M; Gary-Bobo M; Esclangon A; Maffrand JP; Le Fur G; Oury-Donat F; Soubrié P
Mol Pharmacol; 2003 Apr; 63(4):908-14. PubMed ID: 12644592
[TBL] [Abstract][Full Text] [Related]
6. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.
Jbilo O; Ravinet-Trillou C; Arnone M; Buisson I; Bribes E; Péleraux A; Pénarier G; Soubrié P; Le Fur G; Galiègue S; Casellas P
FASEB J; 2005 Sep; 19(11):1567-9. PubMed ID: 16009704
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents.
Valerio A; Cardile A; Cozzi V; Bracale R; Tedesco L; Pisconti A; Palomba L; Cantoni O; Clementi E; Moncada S; Carruba MO; Nisoli E
J Clin Invest; 2006 Oct; 116(10):2791-8. PubMed ID: 16981010
[TBL] [Abstract][Full Text] [Related]
8. The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase.
Esposito I; Proto MC; Gazzerro P; Laezza C; Miele C; Alberobello AT; D'Esposito V; Beguinot F; Formisano P; Bifulco M
Mol Pharmacol; 2008 Dec; 74(6):1678-86. PubMed ID: 18801918
[TBL] [Abstract][Full Text] [Related]
9. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes.
Gary-Bobo M; Elachouri G; Scatton B; Le Fur G; Oury-Donat F; Bensaid M
Mol Pharmacol; 2006 Feb; 69(2):471-8. PubMed ID: 16282221
[TBL] [Abstract][Full Text] [Related]
10. CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice.
Jourdan T; Djaouti L; Demizieux L; Gresti J; Vergès B; Degrace P
Diabetes; 2010 Apr; 59(4):926-34. PubMed ID: 20110567
[TBL] [Abstract][Full Text] [Related]
11. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
12. Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice.
Nam DH; Lee MH; Kim JE; Song HK; Kang YS; Lee JE; Kim HW; Cha JJ; Hyun YY; Kim SH; Han SY; Han KH; Han JY; Cha DR
Endocrinology; 2012 Mar; 153(3):1387-96. PubMed ID: 22234468
[TBL] [Abstract][Full Text] [Related]
13. eNOS plays a major role in adiponectin synthesis in adipocytes.
Koh EH; Kim M; Ranjan KC; Kim HS; Park HS; Oh KS; Park IS; Lee WJ; Kim MS; Park JY; Youn JH; Lee KU
Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E846-53. PubMed ID: 20124507
[TBL] [Abstract][Full Text] [Related]
14. Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages.
Miranville A; Herling AW; Biemer-Daub G; Voss MD
Obesity (Silver Spring); 2010 Dec; 18(12):2247-54. PubMed ID: 20379144
[TBL] [Abstract][Full Text] [Related]
15. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
[TBL] [Abstract][Full Text] [Related]
16. Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.
Tam J; Godlewski G; Earley BJ; Zhou L; Jourdan T; Szanda G; Cinar R; Kunos G
Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E457-68. PubMed ID: 24381003
[TBL] [Abstract][Full Text] [Related]
17. Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway.
Xing SS; Yang XY; Zheng T; Li WJ; Wu D; Chi JY; Bian F; Bai XL; Wu GJ; Zhang YZ; Zhang CT; Zhang YH; Li YS; Jin S
Vascul Pharmacol; 2015 Sep; 72():141-52. PubMed ID: 26187353
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice.
Bajzer M; Olivieri M; Haas MK; Pfluger PT; Magrisso IJ; Foster MT; Tschöp MH; Krawczewski-Carhuatanta KA; Cota D; Obici S
Diabetologia; 2011 Dec; 54(12):3121-31. PubMed ID: 21987346
[TBL] [Abstract][Full Text] [Related]
19. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.
Ravinet Trillou C; Delgorge C; Menet C; Arnone M; Soubrié P
Int J Obes Relat Metab Disord; 2004 Apr; 28(4):640-8. PubMed ID: 14770190
[TBL] [Abstract][Full Text] [Related]
20. Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial function in rats fed a high-fat diet.
Flamment M; Gueguen N; Wetterwald C; Simard G; Malthièry Y; Ducluzeau PH
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1162-70. PubMed ID: 19724020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
